Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation

Chemico-Biological Interactions

Volumn 171, Issue 1, 2008, Pages 89-95

  Albrecht, Daniel S ^a   Clubbs, Elizabeth A ^a   Ferruzzi, Mario ^b   Bomser, Joshua A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Epigallocatechin 3 gallate; Extracellular signal regulated kinase; Green tea; Prostate cancer

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; EPIGALLOCATECHIN GALLATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; MALE; PROSTATE CANCER; PROSTATE EPITHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTICARCINOGENIC AGENTS; CATECHIN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMONES; ENZYME ACTIVATION; EPITHELIAL CELLS; FLAVONOIDS; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MORPHOLINES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE INHIBITORS;

EID: 36549018962     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.09.001     Document Type: Article

References (34)

1. American Cancer Society, Cancer Facts and Figures, 2007, http://www.cancer.org.
2. Chan J.M., Gann P.H., and Giovannucci E.L. Role of diet in prostate cancer development in progression. J. Clin. Oncol. 23 (2005) 8152-8160
3. Jian L., Xie L.P., Lee A.H., and Binns C.W. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer 108 (2004) 130-135
4. Chen L.L., Ye Z.Q., and Koo M.W.L. Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumor cell line. BJU Int. 93 (2004) 1082-1086
5. Liao S., Umekita Y., Guo J., Kokontis J.M., and Hiipakki R.A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 96 (1995) 239-243
6. Yu H.N., Shen S.R., and Yin J.J. Effects of interactions of EGCG and Cd(2+) on the growth of PC-3 cells and their mechanisms. Food Chem. Toxicol. 45 (2007) 244-249
7. Shenouda N.S., Zhou C., Browning J.D., Ansell P.J., Sakla M.S., Lubahn D.B., and Macdonald R.S. Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutr. Cancer 49 (2004) 200-208
8. Paschka A.G., Butler R., and Young C.Y.F. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 130 (1998) 1-7
9. Uzgare A.R., and Isaacs J.T. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Cancer Res. 64 (2004) 6190-6199
10. Ghosh P.M., Malik S., Bedolla R., and Kreisberg J.I. Akt in prostate cancer: possible role in androgen-independence. Curr. Drug Metab. 4 (2003) 487-496
11. Paweletz C.P., Charboneau L., Bichsel V., Simone N.L., Chen T., Gillespie J.W., Emmert-Buck M.R., Roth M.J., Petricon III E.F., and Liotta L.A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20 (2001) 1981-1989
12. Malik S.N., Brattain M., Ghosh P.M., Troyer D.A., Prihoda T., Bedolla R., and Kreisberg J.I. Immunohistochemical demonstration of phospho-AKT in high Gleason grade prostate cancer. Cancer Clin. Can. Res. 8 (2002) 1168-1171
13. Siddiqui I.A., Adhami V.M., Afaq F., Ahmad N., and Mukhtar H. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J. Cell. Biochem. 91 (2004) 232-242
14. Willis M.S., and Wians F.H. The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin. Chim. Acta 330 (2003) 57-83
15. Henning S.M., Aronson W., Niu Y., Conde F., Lee N.H., Seeram N.P., Lee R.P., Lu J., Harris D.M., Moro A., Hong J., Pak-Shan L., Barnard R.J., Ziaee H.G., Csathy G., Go V.L.W., Wang H., and Heber D. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J. Nutr. 136 (2006) 1839-1843
16. Adhami V.M., Siddiqui I.A., Ahmad N., Gupta S., and Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 64 (2004) 8715-8722
17. Gupta S., Hastak K., Ahmad N., Lewin J.S., and Mukhtar H. Inhibition of prostate cancer carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10350-10355
18. Caporali A., Davalli P., Astancolle S., D'Arca D., Brausi D.M., Bettuzzi S., and Corti A. The chemopreventative action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis 25 (2004) 2217-2224
19. Hastak K., Gupta S., Ahmad N., Agarwal M.K., Agarwal M.L., and Mukhtar H. Role of p53 and NF-kB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22 (2003) 4851-4859
20. Bhatia N., and Agarwal R. Detrimental effect of cancer preventative phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells. Prostate 46 (2001) 98-107
21. Chung L.Y., Cheung T.C., Kong S.K., Fung K.P., Choy Y.M., Chan Z.Y., and Kwok T.T. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 68 (2001) 1207-1214
22. Gupta S., Ahmad N., Nieminen A.L., and Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 164 (2000) 82-90
23. Bos J.L. Ras oncogenes in human cancer: a review. Cancer Res. 49 (1989) 4682-4689
24. Moro L., Arbini A.A., Marra E., and Greco M. Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. Int. J. Oncol. 30 (2007) 217-224
25. Xiao D., and Singh S.V. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res. 62 (2002) 3615-3619
26. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
27. York R.D., Yao H., Dillon T., Ellig C.L., Eckert S.P., McCleskey E.W., and Stork P.J. Rap 1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392 (1998) 622-626
28. Frey R.S., and Mulder K.M. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer. Cancer Res. 57 (1997) 628-633
29. Grammer T.C., and Blenis J. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases. Oncogene 14 (1997) 1635-1642
30. Sharrard R.M., and Maitland N.J. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Cell. Signal. 19 (2007) 129-138
31. Shukla S., Maclennan G.T., Hartman D.J., Fu P., Resnick M.I., and Gupta S. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int. J. Cancer 121 (2007) 1424-1432
32. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
33. Zimmermann S., and Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286 (1999) 1741-1744
34. McMenamin M.E., Soung P., Perera S., Kaplan I., Loda M., and Sellers W.R. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res. 59 (1999) 4291-4296